Trial NCT00808210

View at ClinicalTrials.gov 
Org. Study IDs: ACT4562g
Secondary IDs: GA00931

Last trial update was posted on 2020-11-06

MeSH Interventions

Infliximab Methotrexate Methylprednisolone Ocrelizumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.

Limitations And Caveats

At the time of study termination the scope of the statistical analyses was reduced and limited to evaluation of the safety profile.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID